No. |
Product Name |
CAS No. |
Spec |
Price |
|
| LR-2814 |
Recombinant HIV-1p31 |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-2711 |
Recombinant HCV-Core antigens |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-2712 |
Recombinant HCV-NS3 antigens |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-2713 |
Recombinant HCV-NS4 antigens |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-2714 |
Recombinant HCV-NS5 antigens |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-2815 |
Recombinant HIV-1 ’0’ group consensus |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-2816 |
Recombinant HIV-2 gp36 |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-2710 |
Recombinant Multi-epitope Chimeric HCV antigen >95.0% |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-3010 |
Recombinant Tp-chimeric protein |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-3011 |
Recombinant TpN 15 protein |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-3012 |
Recombinant TpN 17 protein |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-3013 |
Recombinant TpN 44.50 protein |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-3014 |
Recombinant TpN 47 protein |
|
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LT-6832 |
Triamcinolone acetonide ≥98% |
76-25-5 |
| 50 mg |
Inquiry |
| 250 mg |
Inquiry |
| 1 g |
Inquiry |
|
|
| LG-0278 |
Gatifloxacin ≥98% |
112811-59-3 |
| 500 mg |
Inquiry |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
|
|
| LA-0025 |
17-Allylaminogeldamamycin ≥97% |
75747-14-7 |
| 0.5 mg |
Inquiry |
| 1 mg |
Inquiry |
| 5 mg |
Inquiry |
|
|
| LA-0501 |
Abamectin ≥70% |
71751-41-2 |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
| 25 g |
Inquiry |
|
|
| LA-0920 |
N-Acetyl-S-(N’-phenethylthiocarbamoyl)-L-cysteine ≥95% |
|
| 25 mg |
Inquiry |
| 100 mg |
Inquiry |
| 500 mg |
Inquiry |
|
|
| LA-0978 |
Actinonin ≥98% |
13434-13-4 |
|
|
| LA-1332 |
Adipokinetic Hormone II from Locusta migratoria ≥98% |
|
| 1 mg |
Inquiry |
| 2 mg |
Inquiry |
| 5 mg |
Inquiry |
|
|
